Face to Face Hot Stocks: Colony Capital, Inc. (NYSE:CLNY), Chemours Company (The) (NYSE:CC)

nyse

Colony Capital, Inc. (NYSE:CLNY)

Colony Capital, Inc. (NYSE:CLNY) closed at $4.9 on the last trading session with an increase of 0.41%, whereas, it previously closed at $4.88. The company has a market capitalization of $2.4 Billion. The company traded shares of 2.1 Million on the trading day while its three month average volume stands at 2.8 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Colony Capital, Inc. (NYSE:CLNY) produced diluted EPS of -3.26. The EPS estimate for next year as estimated by analysts is at -0.46 while EPS for next quarter is estimated at -0.15. Earnings per Share growth for this year is reported at -79.4, while the analysts estimated the EPS growth for next year at -0.46% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 5.44%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Colony Capital, Inc. (NYSE:CLNY) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Colony Capital, Inc. (NYSE:CLNY) stands at 1 and Price to Book or P/B for the most recent quarter stands at 0.55. The Price to Free Cash Flow ratio or P/FCF is reported at 17.97. The quick ratio and the current ratio of Colony Capital, Inc. (NYSE:CLNY) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Colony Capital, Inc. (NYSE:CLNY) stands at -7, -31 and -3.4 respectively

The trailing twelve month Revenue of Colony Capital, Inc. (NYSE:CLNY) is reported at 2.41 Billion with income of -1565700000. The outstanding shares of Colony Capital, Inc. (NYSE:CLNY) are 490.74 Million. The institutional Ownership of the shares of 82.7 stands at 0.80%, this figure is increased 0.63 in the last six months. The insider ownership for the shares of Colony Capital, Inc. (NYSE:CLNY) is ticked at 2.42%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Colony Capital, Inc. (NYSE:CLNY) is the Mean Target Price estimated by the analysts which stands at 7. The 52 week high of Colony Capital, Inc. (NYSE:CLNY) is placed at 6.28 and 52 week low is standing at 4.32.

Performance wise the shares of Colony Capital, Inc. (NYSE:CLNY) fell down -1.01% for the week, it also fell -12.5% for the monthly performance, while for the quarter it went down 5.15%. The shares decrease -4.48% for the half year and flew up for the Year-To-Date performance. The shares of Colony Capital, Inc. (NYSE:CLNY) shrinked -18.47% for the yearly performance.

Chemours Company (The) (NYSE:CC)

Chemours Company (The) (NYSE:CC) closed at $15.71 on the last trading session with an decrease of -0.51%, whereas, it previously closed at $15.79. The company has a market capitalization of $2.63 Billion. The company traded shares of 1.65 Million on the trading day while its three month average volume stands at 2.54 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Chemours Company (The) (NYSE:CC) produced diluted EPS of 2.39. The EPS estimate for next year as estimated by analysts is at 3.35 while EPS for next quarter is estimated at 0.49. Earnings per Share growth for this year is reported at 31.3, while the analysts estimated the EPS growth for next year at 3.35% and Earnings growth for next 5 years stands at -8.8% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 18.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Chemours Company (The) (NYSE:CC) is at 6.58 while the forward p/e is at 4.69. The P/S or Price to Sales ratio of Chemours Company (The) (NYSE:CC) stands at 0.47 and Price to Book or P/B for the most recent quarter stands at 3.07. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Chemours Company (The) (NYSE:CC) are reported at 1 and 1.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Chemours Company (The) (NYSE:CC) stands at 5.5, 46.8 and 19.6 respectively

The trailing twelve month Revenue of Chemours Company (The) (NYSE:CC) is reported at 5.64 Billion with income of 408 Million. The outstanding shares of Chemours Company (The) (NYSE:CC) are 167.12 Million. The institutional Ownership of the shares of 78.8 stands at 0.80%, this figure is decreased -3.39 in the last six months. The insider ownership for the shares of Chemours Company (The) (NYSE:CC) is ticked at 0.5%, the figure is rose 13.79% in the last six months.

Some other important financial aspects to be discussed here for Chemours Company (The) (NYSE:CC) is the Mean Target Price estimated by the analysts which stands at 25.08. The 52 week high of Chemours Company (The) (NYSE:CC) is placed at 41.60 and 52 week low is standing at 11.71.

Performance wise the shares of Chemours Company (The) (NYSE:CC) fell down -2.18% for the week, it also fell -4.27% for the monthly performance, while for the quarter it went down 17.68%. The shares decrease -31.9% for the half year and plummeted for the Year-To-Date performance. The shares of Chemours Company (The) (NYSE:CC) shrinked -44.88% for the yearly performance.